Industry payments to physicians linked to use of some non-recommended and low-value drugs among cancer patients
Patients with cancer whose oncologists receive payments from industry appear more likely to receive some non-recommended and low-value treatments, finds a US study published by The BMJ today.
Oct 25, 2023
0
0